3.4 Effect of 180 days treatment on biochemical markers of atherosclerotic plaque vulnerability
After a 180-day intervention with GLP-1 RA in our study group, we observed a statistically significant decrease in biochemical markers associated with atherosclerotic plaque instability, including PTX3, CPC, MMP-9 (p < 0.001), and (p < 0.05) for Lp(a). The results are presented in Figures 6-9